British Journal of Dermatology · 1977 · 151 citations · 17 references
MedicineDermatologyPharmacotherapyCosmetic DermatologyDermatopathologyPhotodermatologyHyperpigmentation TreatmentPigmentary DisordersSkin CareContact Dermatitis PathologyGeneralized HyperpigmentationGeneralized HypopigmentationLocalized HypopigmentationTopical Depigmenting TherapyTopical Hydroquinone TherapyVitiligo PhototherapyVitiligo Treatment
Of 18 severely afffected vitiligo patients who used 20% monobenzylether of hydroquinone (MBEH, Benoquin) as a depigmenting agent, 8 achieved complete depigmentation after 10 months or more of use and 3 dramatic but no complete hypopigmentation. The 3 patients with no results did not use MBEH for more than 4 months. Complications were frequent particularly among those who did well, but only 1 case of contact dermatitis limited therapy. All patients who depigmented fully were very pleased with their results. As depigmentation induced by MBEH is generally irreversible, MBEH use must be reserved for induction of complete depigmentation of severely affected vitiligo patients who cannot or do not choose to repigment and who can accept the permanence of never tanning. The history, histology and mechanism of MBEH depigmentation are discussed.
17
Mechanism of Depigmentation by Hydroquinone
Kowichi Jimbow, Hiroko Obata, Madhu A. Pathak et al. · Journal of Investigative Dermatology · 1974 · 321 citations · Full text
Industrial Medicine and Surgery.
Harry Edgar Mock · Journal of the American Medical Association · 1920 · 232 citations · Full text
Edward A. Oliver · Archives of Dermatology · 1940 · 130 citations
Medicine, Dermatology, Pathology +9